Fatigue News and Research

RSS

Tibotec to present Week-24 interim analysis of PILLAR study for chronic HCV treatment at AASLD Meeting

Tibotec Pharmaceuticals announced today the company will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA., USA. The data will be presented as part of a late-breaker oral presentation on Monday, November 1.

1 Nov 2010

Study finds SBRT therapy delays pancreatic cancer progression

For pancreatic cancer patients unable to undergo surgery the only known cure for this form of cancer a highly targeted cancer radiation therapy may help slow cancer progression and lessen disease symptoms, according to researchers at Henry Ford Hospital in Detroit.

30 Oct 2010

Bed rest may harm mother and baby in pregnancy complications

Bed rest may not be the best option for preventing preterm labor and may even cause harm to the mother and baby, according to an integrative literature review in a special issue on "Women's Health Across the Lifespan" in Biological Research for Nursing (published by SAGE).

30 Oct 2010

University of Maryland to establish major research enterprise for autoimmune diseases

With a new $45 million private gift from the family of a grateful patient, the University of Maryland School of Medicine is planning to establish the nation's only major research enterprise devoted to the study of autoimmune and inflammatory diseases such as celiac disease, multiple sclerosis, chronic obstructive pulmonary disease, asthma and Type 1 diabetes. The gift, from Indiana couple Ken and Shelia Cafferty, is the largest private donation in the history of the University System of Maryland.

29 Oct 2010

Coadministration of INTUNIV tablets with stimulant reduces ADHD symptoms

Shire plc the global specialty biopharmaceutical company, today presented research results of once-daily INTUNIV (guanfacine) Extended-Release Tablets, coadministered with stimulants in children and adolescents diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) who had suboptimal response to treatment with a long-acting stimulant alone.

29 Oct 2010

Low household income associated with chronic migraine

New data presented today at The 2010 European Headache and Migraine Trust International Congress (EHMTIC) shows that persons with chronic migraine (headache on greater than or equal to 15 days per month) are much more likely to have annual household incomes below $30,000 than those with episodic migraine (headache on < 15 days per month).

29 Oct 2010

Calypso Medical initiates clinical study to evaluate tracking technology for lung tumors

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumors, today announced the initiation of the first clinical study to evaluate the use of the Calypso System for tracking lung cancer tumors during radiation delivery, including a new design of the Company's implantable Beacon transponder.

28 Oct 2010

Vertex initiates OPTIMIZE Phase 3b study in patients infected with genotype 1 HCV

Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.

26 Oct 2010

Paramedics at risk of stress, anxiety and depression: Study

According to the latest research paramedics are at a high risk of stress and depression. The Victorian study showed that around ten per cent of paramedics were found to have severe or extremely severe depression, while 40 per cent reported feeling the effects of stress. Nearly 25% were also found to suffer an “above normal degree of anxiety”.

25 Oct 2010

Safety tips to reduce risk of lead exposure

With more than 2,700 children having elevated blood lead levels in 2009, the Department of Health today reminds parents to test young children for lead exposure, especially during National Lead Poisoning Prevention Week, Oct. 24-30.

25 Oct 2010

Gene therapy may reverse pulmonary hypertension

A Heart and Stroke Foundation researcher has discovered what could be the first truly effective breakthrough in the diagnosis and treatment of pulmonary hypertension, a devastating, life-threatening condition which results in an enlargement of the heart.

25 Oct 2010

Fred Hutchinson Center offers research-based tip sheets for breast cancer survivors

Throughout October, National Breast Cancer Awareness Month, experts from Fred Hutchinson Cancer Research Center and its clinical care partner, the Seattle Cancer Care Alliance, are offering weekly research-based tip sheets regarding breast cancer prevention, screening and early detection, treatment and survivorship.

25 Oct 2010

Nurses in health care facilities may perform better through harm reduction strategies: Researchers

University of Maryland School of Nursing researchers say nurses in hospitals and other health care facilities may perform better by following the lead of airlines, trucking, and nuclear plants, by limiting hours of service, ensuring prompt and definite breaks during shifts, and other scheduling strategies.

22 Oct 2010

Snoring may destroy grey matter

A new Australian study has found that snoring and troubled nights could be a warning of brain damage occurring while sleeping. The team looked at brain scans of 60 people, aged in their mid-40s and recently diagnosed with a common sleep disorder – obstructive sleep apnea. Obstructive sleep apnea often affects overweight and the obese and leads to snoring. Results showed “decreased amount of grey matter” when compared to healthy sleepers.

21 Oct 2010

Effects of breast cancer do not end after chemotherapy

For some women, the effects of breast cancer, the most common cancer affecting women, do not end when they leave the hospital. Now, researchers in the University of Missouri School of Health Professions have studied the lives of breast cancer patients following chemotherapy and found that their environments and available support systems help determine the quality of their lives.

21 Oct 2010

U-M hopes to make concept of recycling pacemakers a life-saving reality

Millions worldwide die each year because they can't afford a pacemaker. Meanwhile heart patients in the United States say they'd be willing to donate theirs after death to someone in need.

20 Oct 2010

Dexamethasone improves quality of life after laparoscopic gallbladder surgery

A study presented at the American Society of Anesthesiologists 2010 Annual Meeting in San Diego seems to confirm that a single, small dose of the steroid dexamethasone improves the post-surgical quality of life of patients receiving laparoscopic gallbladder surgery.

20 Oct 2010

Moderate amount of protein in low-carb beverage improves aerobic endurance: Report

Compared to a standard carbohydrate supplement, a low-carbohydrate beverage with added protein leads to longer endurance times in cyclists, reports the October issue of the The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.

19 Oct 2010

Survey reveals impact of insomnia during menopause

Results released today from a survey of more than 900 women, who experienced sleep problems during menopause, shed light on the impact insomnia can have during this time in a woman's life. The survey also revealed that for many women, insomnia during menopause is not proactively addressed by their healthcare provider (HCP) and that often times, women don't communicate their symptoms to their HCP.

19 Oct 2010

Studies explore impact of upper GI conditions on sleep

The impact of upper GI conditions, like gastroesophageal reflux disease (GERD) and functional dyspepsia, on sleep—and treatments aimed at providing relief to heartburn/acid reflux patients who suffer from disordered sleep—were explored in three new studies related to sleep dysfunction presented today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.

18 Oct 2010

Fatigue News and Research

Tibotec to present Week-24 interim analysis of PILLAR study for chronic HCV treatment at AASLD Meeting

Study finds SBRT therapy delays pancreatic cancer progression

Bed rest may harm mother and baby in pregnancy complications

University of Maryland to establish major research enterprise for autoimmune diseases

Coadministration of INTUNIV tablets with stimulant reduces ADHD symptoms

Low household income associated with chronic migraine

Calypso Medical initiates clinical study to evaluate tracking technology for lung tumors

Vertex initiates OPTIMIZE Phase 3b study in patients infected with genotype 1 HCV

Paramedics at risk of stress, anxiety and depression: Study

Safety tips to reduce risk of lead exposure

Gene therapy may reverse pulmonary hypertension

Fred Hutchinson Center offers research-based tip sheets for breast cancer survivors

Nurses in health care facilities may perform better through harm reduction strategies: Researchers

Snoring may destroy grey matter

Effects of breast cancer do not end after chemotherapy

U-M hopes to make concept of recycling pacemakers a life-saving reality

Dexamethasone improves quality of life after laparoscopic gallbladder surgery

Moderate amount of protein in low-carb beverage improves aerobic endurance: Report

Survey reveals impact of insomnia during menopause

Studies explore impact of upper GI conditions on sleep

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News